Umeå University's logo

umu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Bladder cancer recurrence in papillary urothelial neoplasm of low malignant potential (PUNLMP) compared to G1 WHO 1999: a population-based study
Show others and affiliations
2022 (English)In: Scandinavian journal of urology, ISSN 2168-1805, E-ISSN 2168-1813, Vol. 56, p. 14-18Article in journal (Refereed) Published
Abstract [en]

OBJECTIVE: Papillary urothelial neoplasm of low malignant potential (PUNLMP) and stage TaG1 non-muscle invasive bladder cancer (NMIBC) represent separate categories in current WHO 1999 grade definitions. Similarly, PUNLMP and Ta low-grade are separate entities in the WHO 2004/2016 grading system. However, this classification is currently questioned by reports showing a similar risk of recurrence and progression for both categories.

PATIENTS AND METHODS: In this population-based study, risk estimates were evaluated in patients diagnosed with PUNLMP (n = 135) or stage TaG1 (n = 2176) NMIBC 2004-2008 with 5-year follow-up registration in the nation-wide Bladder Cancer Data Base Sweden (BladderBaSe). The risk of recurrence was assessed using multivariable Cox regression with adjustment for multiple confounders (age, gender, marital status, comorbidity, educational level, and health care region).

RESULTS: At five years, 28/135 (21%) patients with PUNLMP and 922/2176 (42%) with TaG1 had local recurrence. The corresponding progression rates were 0.7% (1/135) and 4.0% (86/2176), respectively. A higher relative risk of recurrence was detected in patients with TaG1 tumours compared to PUNLMP (Hazard Ratio 1.6, 95% CI 1.2-2.0) at 5-year follow-up, while progression events were too few to compare.

CONCLUSIONS: The difference in risk of recurrence between primary stage TaG1 and PUNLMP stands in contrast to the recently adapted notion that treatment and follow-up strategies can be merged into one low-risk group of NMIBC.

Place, publisher, year, edition, pages
Taylor & Francis Group, 2022. Vol. 56, p. 14-18
Keywords [en]
PUNLMP, Papillary urothelial neoplasm of low malignant potential, bladder cancer, grade 1, recurrence
National Category
Urology and Nephrology
Identifiers
URN: urn:nbn:se:umu:diva-188488DOI: 10.1080/21681805.2021.1987980ISI: 000705430200001PubMedID: 34623216Scopus ID: 2-s2.0-85116680712OAI: oai:DiVA.org:umu-188488DiVA, id: diva2:1601768
Funder
Swedish Cancer Society, 2019/62Swedish Cancer Society, 2017/278Available from: 2021-10-11 Created: 2021-10-11 Last updated: 2023-03-24Bibliographically approved

Open Access in DiVA

fulltext(1414 kB)183 downloads
File information
File name FULLTEXT01.pdfFile size 1414 kBChecksum SHA-512
d07ef08f1a598abb9670d667221776da5d312bde46a6847edd6cf7c0c4d623e4f74157c649736ce40804e1293a23c09cf90bba12e45b1f7ec4ef449f0436b996
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMedScopus

Authority records

Sherif, AmirHäggström, Christel

Search in DiVA

By author/editor
Sherif, AmirHäggström, Christel
By organisation
Urology and AndrologyNutritional Research
In the same journal
Scandinavian journal of urology
Urology and Nephrology

Search outside of DiVA

GoogleGoogle Scholar
Total: 183 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 213 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf